Title
COVID-19 Guideline Part 4: Serologic Testing
Authoring Organization
Publication Month/Year
August 18, 2020
Document Type
Guideline
Country of Publication
US
Document Objectives
IDSA’s goal was to develop evidence-based recommendations that assist clinicians, clinical laboratories, patients and policymakers in decisions related to the optimal use of SARS-CoV-2 serologic tests in a variety of settings. We also highlight important unmet research needs pertaining to the use of anti-SARS-CoV-2 antibody tests for diagnosis, public health surveillance, vaccine development and the selection of convalescent plasma donors.
Inclusion Criteria
Male, Female, Adolescent, Adult, Child, Older adult
Health Care Settings
Ambulatory, Hospital, Laboratory services
Intended Users
Epidemiology infection prevention, laboratory technician, nurse, nurse practitioner, physician, physician assistant
Scope
Diagnosis, Assessment and screening
Diseases/Conditions (MeSH)
D000086382 - COVID-19, D000087124 - COVID-19 Serological Testing
Keywords
covid-19, serologic testing, COVID, serological testing
Supplemental Methodology Resources
Data Supplement, Evidence Tables, Data Supplement, Data Supplement, Data Supplement, Data Supplement